{
 "url": "https://etfiq.com/funds/medx/holdings/",
 "section": "funds",
 "title": "MEDX Holdings: All 31 Positions (Jun 30, 2026) | ETFIQ",
 "description": "All 31 MEDX holdings with weights, as of Jun 30, 2026. The top 3 are LLY 18.46%, ABBV 8.85% and NVS 6.89%. Download the full list as a CSV.",
 "as_of": "Jun 30, 2026",
 "ticker": "MEDX",
 "fund": "Horizon Kinetics Medical ETF",
 "fund_page": "https://etfiq.com/funds/medx",
 "positions": 31,
 "positions_listed_on_page": 31,
 "lead": "MEDX held 31 positions as of Jun 30, 2026. Eli Lilly & Co is the largest at 18.46%; the top 10 are 67.1% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/1683471/000119312526367636/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-06-30",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 18.46,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 2,
   "holding": "AbbVie Inc",
   "ticker": "ABBV",
   "weight_pct": 8.854,
   "page": "https://etfiq.com/holdings/abbv/"
  },
  {
   "rank": 3,
   "holding": "Novartis AG",
   "ticker": "NVS",
   "weight_pct": 6.891,
   "page": null
  },
  {
   "rank": 4,
   "holding": "Johnson & Johnson",
   "ticker": "JNJ",
   "weight_pct": 5.591,
   "page": "https://etfiq.com/holdings/jnj/"
  },
  {
   "rank": 5,
   "holding": "Alkermes PLC",
   "ticker": "ALKS",
   "weight_pct": 5.529,
   "page": "https://etfiq.com/holdings/alks/"
  },
  {
   "rank": 6,
   "holding": "AstraZeneca PLC",
   "ticker": "AZN",
   "weight_pct": 4.985,
   "page": "https://etfiq.com/holdings/azn/"
  },
  {
   "rank": 7,
   "holding": "Ionis Pharmaceuticals Inc",
   "ticker": "IONS",
   "weight_pct": 4.532,
   "page": "https://etfiq.com/holdings/ions/"
  },
  {
   "rank": 8,
   "holding": "Bristol-Myers Squibb Co",
   "ticker": "BMY",
   "weight_pct": 4.423,
   "page": "https://etfiq.com/holdings/bmy/"
  },
  {
   "rank": 9,
   "holding": "Merck & Co Inc",
   "ticker": "MRK",
   "weight_pct": 3.955,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 10,
   "holding": "Amgen Inc",
   "ticker": "AMGN",
   "weight_pct": 3.914,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 11,
   "holding": "Alnylam Pharmaceuticals Inc",
   "ticker": "ALNY",
   "weight_pct": 3.421,
   "page": "https://etfiq.com/holdings/alny/"
  },
  {
   "rank": 12,
   "holding": "Biogen Inc",
   "ticker": "BIIB",
   "weight_pct": 3.087,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 13,
   "holding": "Pfizer Inc",
   "ticker": "PFE",
   "weight_pct": 2.859,
   "page": "https://etfiq.com/holdings/pfe/"
  },
  {
   "rank": 14,
   "holding": "GSK PLC",
   "ticker": "GSK",
   "weight_pct": 2.706,
   "page": "https://etfiq.com/holdings/gsk-plc/"
  },
  {
   "rank": 15,
   "holding": "CRISPR Therapeutics AG",
   "ticker": "CRSP",
   "weight_pct": 2.638,
   "page": "https://etfiq.com/holdings/crsp/"
  },
  {
   "rank": 16,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 2.059,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 17,
   "holding": "Beam Therapeutics Inc",
   "ticker": "BEAM",
   "weight_pct": 1.509,
   "page": "https://etfiq.com/holdings/beam/"
  },
  {
   "rank": 18,
   "holding": "Galectin Therapeutics Inc",
   "ticker": "GALT",
   "weight_pct": 1.142,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Intellia Therapeutics Inc",
   "ticker": "NTLA",
   "weight_pct": 1.116,
   "page": "https://etfiq.com/holdings/ntla/"
  },
  {
   "rank": 20,
   "holding": "Sandoz Group AG",
   "ticker": "SDZNY",
   "weight_pct": 0.797,
   "page": "https://etfiq.com/holdings/sdz/"
  },
  {
   "rank": 21,
   "holding": "Replimune Group Inc",
   "ticker": "REPL",
   "weight_pct": 0.73,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Vanda Pharmaceuticals Inc",
   "ticker": "VNDA",
   "weight_pct": 0.727,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Haleon PLC",
   "ticker": "HLN",
   "weight_pct": 0.602,
   "page": "https://etfiq.com/holdings/hln/"
  },
  {
   "rank": 24,
   "holding": "Lantern Pharma Inc",
   "ticker": "LTRN",
   "weight_pct": 0.55,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Editas Medicine Inc",
   "ticker": "EDIT",
   "weight_pct": 0.47,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 7.358
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/medx/holdings/medx-holdings.csv",
 "json_book": "https://etfiq.com/data/books/medx.json",
 "markdown": "https://etfiq.com/funds/medx/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of MEDX, data as of Jun 30, 2026. https://etfiq.com/funds/medx/holdings/"
}